SWOG clinical trial number
S2101

Biomarker Stratified CaboZantinib and NivOlumab (BiCaZO) - A phase II study of combining caboza8/3/2021ntinib and nivolumab in patients with advanced solid tumors stratified by tumor biomarkers

Open
Abbreviated Title
BiCaZO - iMATCH pilot

Research committees

iMATCH
Head and Neck Cancer
Melanoma
Early Therapeutics & Rare Cancers

Treatment

Cabozantinib Nivolumab